(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of 7.1% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.07%.
Masimo's revenue in 2026 is $1,558,500,000.On average, 12 Wall Street analysts forecast MASI's revenue for 2026 to be $86,822,509,664, with the lowest MASI revenue forecast at $82,895,074,064, and the highest MASI revenue forecast at $89,754,994,912. On average, 11 Wall Street analysts forecast MASI's revenue for 2027 to be $93,472,967,280, with the lowest MASI revenue forecast at $88,707,678,752, and the highest MASI revenue forecast at $96,876,744,800.
In 2028, MASI is forecast to generate $100,332,888,128 in revenue, with the lowest revenue forecast at $94,939,209,904 and the highest revenue forecast at $104,888,713,424.